Application 202931
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FROVATRIPTAN SUCCINATE | FROVATRIPTAN SUCCINATE | TABLET;ORAL | EQ 2.5MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202931-001 | FROVATRIPTAN SUCCINATE | FROVATRIPTAN SUCCINATE | EQ 2.5MG BASE | TABLET / ORAL | 2014-08-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A202931-001 | FROVATRIPTAN SUCCINATE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2014-08-28 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A202931-001 | FROVATRIPTAN SUCCINATE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2014-08-28 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A202931-001 | FROVATRIPTAN SUCCINATE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2014-08-28 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A202931-001 | FROVATRIPTAN SUCCINATE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2014-08-28 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A202931-001 | FROVATRIPTAN SUCCINATE | EQ 2.5MG BASE | TABLET / ORAL | 2014-08-28 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202931-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A202931-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A202931-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A202931-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A202931-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A202931-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A202931-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A202931-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A202931-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A202931-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A202931-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A202931-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A202931-001 | AB | 1 | ea99ee380514… |
| 2023-05-13 08:27 UTC | 2023-05 | A202931-001 | AB | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A202931-001 | AB | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A202931-001 | AB | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A202931-001 | AB | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A202931-001 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A202931-001 | AB | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FROVATRIPTAN SUCCINATE | FROVATRIPTAN SUCCINATE | Leading Pharma, LLC | d303af88-e0c1-4fb2-ba8e-83b7e6d163cd | 2026-06-27 | Warnings, Adverse reactions | FROVATRIPTAN SUCCINATE FROVATRIPTAN SUCCINATE |
| frovatriptan succinate | FROVATRIPTAN SUCCINATE | Glenmark Pharmaceuticals Inc., USA | 03a58215-dba7-4f63-8b98-d74d054a574a | 2026-01-28 | Warnings, Adverse reactions | frovatriptan succinate FROVATRIPTAN SUCCINATE |
| FROVATRIPTAN | FROVATRIPTAN SUCCINATE | Ingenus Pharmaceuticals, LLC | 92c91060-c06e-4a8a-b586-a3fb25c33433 | 2025-11-26 | Warnings, Adverse reactions | FROVATRIPTAN SUCCINATE |
| Frovatriptan | FROVATRIPTAN SUCCINATE | Amneal Pharmaceuticals NY LLC | 94b996dc-ddc4-41ce-9a9f-3d91cb187473 | 2019-09-30 | Warnings, Adverse reactions | FROVATRIPTAN SUCCINATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-3140 | Frovatriptan | frovatriptan | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3140 | Frovatriptan | frovatriptan | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-3140 | Frovatriptan | frovatriptan | Mylan Pharmaceuticals Inc. | ANDA | Current |